Changho Choi1, Sandeep Ganji2, Akshay Madan1, Robert Bachoo1, Ralph DeBerardinis1, Elizabeth A. Maher1
1University of Texas Southwestern Medical Center, Dallas, TX, United States; 2UT Southwestern Medical Center, Dallas, TX, United States
Given the great potential of 2HG as a biomarker in the diagnosis and management of glioma patients as well as the workup of an undiagnosed mass, the capability of precise detection of 2HG in vivo is extensively needed. In 1H-MRS, the 2HG signals are severely overlapped with other metabolite signals. Specifically, because of the close proximity of the 2HG 2.25 ppm resonance to the GABA 2.29 ppm resonance, when the 2HG levels are relatively low, 2HG estimation is elusive. Here we present 2HG measurements without considerable GABA contamination in patients in vivo, achieved by constant-TE triple-refocusing difference editing at 3T.